Dr. Wendy Webber Nelson is a biotechnology leader and founder of the Boston Biotech Forum, a leading platform connecting innovators across biotech and pharma. She is Managing Partner at Dreavent Capital, serves on the board of SciShield, acts as a Business Advisor for ModernVivo and Cytimmune Biosciences, and is a Venture Partner with Waterman Ventures.
With over 25 years of experience spanning biotech, big pharma, CROs, and startups, she has held leadership roles including Chief Business Officer at Danforth Advisors and CEO of LeadingBiotech. Earlier, she managed business development for multiple global CROs and oversaw project management at Alantos Pharmaceuticals during its $300M acquisition by Amgen. Wendy holds ScB, MS, and PhD degrees from Brown University, has authored numerous patents and scientific publications, and has been active in advocacy and mentoring programs within the biotech community.
